Company Name, Ticker, Suppliers, else..

Vycor Medical Inc (VYCO)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Vycor Medical Inc 's

Name: Vycor Medical Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VYCO Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Vycor Medical Inc reported Revenue decrease in the 2 quarter 2026 year on year by -15.73 %, faster than the overall decrease of Vycor Medical Inc 's competitors by -5.08 %, recorded in the same quarter.

• List of VYCO Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Vycor Medical Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< VYCO Stock Performance Comparisons

Vycor Medical Inc 's Comment on Competition and Industry Peers

Vycor operates two business units: Vycor Medical, which designs and markets neurosurgery medical devices, and NovaVision, which provides non-invasive rehabilitation therapies for vision disorders caused by neurological brain damage. Vycor, through its wholly-owned subsidiary NovaVision, acquired all shares of Sight Science Limited, a former competitor to NovaVision. Both business units emphasize minimally or non-invasive approaches and share resources to improve cost efficiency.

<< See the full list of VYCO competitors

Overall company Market Share Q2 2026

Overall company, revenue fell by -15.73 % and company lost market share, to approximately 0.19 %. << More on VYCO Market Share.

*Market share is calculated based on total revenue.

VYCO's Stock Performance relative to its Competitors

Publicly Traded Peers of Vycor Medical Inc

Mimedx Group Inc
Share Performance

+7.60%

30 Days

Mimedx Group Inc

Profile

MiMedx Group Inc's business model revolves around developing and commercializing regenerative biologics to aid the body's natural healing process.

More about Mimedx Group Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 690.206 mill.	$ 354.086 mill.	$ 6.237 mill.

Myomo Inc
Share Performance

+35.35%

This Year

Myomo Inc

Profile

Myomo Inc's business model revolves around the development and commercialization of advanced medical devices, specifically myoelectric orthotics for individuals with neuromuscular disorders.

More about Myomo Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 56.641 mill.	$ 41.180 mill.	$ -15.118 mill.

Nuo Therapeutics Inc
Share Performance

0.00%

This Year

Nuo Therapeutics Inc

Profile

Nuo Therapeutics Inc's business model revolves around developing and commercializing innovative biologic therapies aimed at improving healthcare outcomes for patients. They focus on the research, development, and marketing of new therapeutic products, primarily in the wound care sector.

More about Nuo Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 4.036 mill.	$ -2.385 mill.

Pavmed Inc
Share Performance

-9.40%

Over The Past 5 Days

Pavmed Inc

Profile

Pavmed Inc is a medical device company that focuses on developing and commercializing innovative products for various medical fields. The company's business model revolves around identifying unmet medical needs, acquiring proprietary rights to potential products, and advancing them through development stages to obtain regulatory approvals and market them.

More about Pavmed Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 29.591 mill.	$ 0.126 mill.	$ -16.430 mill.

Pulse Biosciences Inc
Share Performance

+264.38%

This Year

Pulse Biosciences Inc

Profile

Pulse Biosciences Inc's business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.

More about Pulse Biosciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 3,376.269 mill.	$ 1.185 mill.	$ -80.056 mill.

12 more competitors available

Sources: Vycor Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 10:58 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Vycor Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.